ILF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.64779301314866E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.43294314986542E-13 |
Normal-vs-Stage2 |
4.06810030106897E-10 |
Normal-vs-Stage3 |
9.10316266811151E-12 |
Normal-vs-Stage4 |
3.30910000001516E-06 |
Stage1-vs-Stage2 |
4.669400E-01 |
Stage1-vs-Stage3 |
4.104000E-01 |
Stage1-vs-Stage4 |
8.560100E-02 |
Stage2-vs-Stage3 |
9.895000E-01 |
Stage2-vs-Stage4 |
7.231600E-02 |
Stage3-vs-Stage4 |
5.130300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.63122856836162E-14 |
Normal-vs-AfricanAmerican |
1.20239999956695E-07 |
Normal-vs-Asian |
2.864300E-02 |
Caucasian-vs-AfricanAmerican |
7.170000E-01 |
Caucasian-vs-Asian |
5.388600E-01 |
AfricanAmerican-vs-Asian |
5.084400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.6251444634463E-12 |
Normal-vs-Female |
2.82110002025604E-09 |
Male-vs-Female |
6.916600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.05859999993885E-07 |
Normal-vs-Age(41-60Yrs) |
3.97570865118269E-13 |
Normal-vs-Age(61-80Yrs) |
3.11972669919669E-12 |
Normal-vs-Age(81-100Yrs) |
2.275100E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.873400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.204400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.112400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.060000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.906200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.879400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.226500E-04 |
Normal-vs-Grade 2 |
2.34146035893446E-13 |
Normal-vs-Grade 3 |
5.73874281428743E-13 |
Normal-vs-Grade 4 |
6.15280000282326E-08 |
Grade 1-vs-Grade 2 |
7.949600E-01 |
Grade 1-vs-Grade 3 |
6.697400E-01 |
Grade 1-vs-Grade 4 |
8.904000E-01 |
Grade 2-vs-Grade 3 |
4.686000E-01 |
Grade 2-vs-Grade 4 |
8.760800E-01 |
Grade 3-vs-Grade 4 |
5.407800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.16522413518805E-12 |
Normal-vs-ccB subtype |
2.98683300314906E-12 |
ccA subtype-vs-ccB subtype |
1.188980E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.62434518560895E-12 |
Normal-vs-N1 |
1.600760E-01 |
N0-vs-N1 |
1.011210E-01 |
|
|